Sanofi (SNY) Stock Price Up 5.5%

Share on StockTwits

Sanofi SA (NYSE:SNY) shares rose 5.5% during mid-day trading on Friday . The company traded as high as $44.73 and last traded at $44.21. Approximately 4,716,382 shares changed hands during mid-day trading, an increase of 348% from the average daily volume of 1,052,975 shares. The stock had previously closed at $41.91.

SNY has been the topic of a number of research reports. TheStreet lowered shares of Sanofi from a “b” rating to a “c+” rating in a research note on Thursday, February 7th. HC Wainwright reiterated a “buy” rating on shares of Sanofi in a research note on Thursday, February 28th. Eight equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $51.00.

The company has a market capitalization of $111.46 billion, a price-to-earnings ratio of 14.12, a price-to-earnings-growth ratio of 2.41 and a beta of 0.67. The company has a current ratio of 1.22, a quick ratio of 0.85 and a debt-to-equity ratio of 0.40.

Sanofi (NYSE:SNY) last released its quarterly earnings data on Friday, April 26th. The company reported $0.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.07. The firm had revenue of $8.39 billion for the quarter, compared to analyst estimates of $8.34 billion. Sanofi had a net margin of 12.20% and a return on equity of 18.18%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.28 earnings per share. As a group, research analysts expect that Sanofi SA will post 3.1 earnings per share for the current fiscal year.

Hedge funds have recently added to or reduced their stakes in the stock. Essex Savings Bank acquired a new stake in Sanofi during the fourth quarter valued at $30,000. Claybrook Capital LLC acquired a new stake in shares of Sanofi in the fourth quarter valued at about $31,000. Executive Wealth Management LLC acquired a new stake in shares of Sanofi in the fourth quarter valued at about $34,000. Nkcfo LLC acquired a new stake in shares of Sanofi in the first quarter valued at about $35,000. Finally, Cullen Frost Bankers Inc. acquired a new stake in shares of Sanofi in the first quarter valued at about $35,000. Institutional investors own 7.04% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Sanofi (SNY) Stock Price Up 5.5%” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/4364954/sanofi-sny-stock-price-up-5-5.html.

About Sanofi (NYSE:SNY)

Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Further Reading: How is inflation measured?

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bitcoin Gold  One Day Volume Hits $19.95 Million
Bitcoin Gold One Day Volume Hits $19.95 Million
Dash Market Cap Tops $1.44 Billion
Dash Market Cap Tops $1.44 Billion
Sether Trading Up 0.1% Over Last Week
Sether Trading Up 0.1% Over Last Week
Bitcoin Diamond  Reaches Market Capitalization of $240.36 Million
Bitcoin Diamond Reaches Market Capitalization of $240.36 Million
Siacoin  One Day Trading Volume Hits $1.58 Million
Siacoin One Day Trading Volume Hits $1.58 Million
Tether  Trading 0.1% Lower  This Week
Tether Trading 0.1% Lower This Week


© 2006-2019 Ticker Report